CTRI/2018/01/011414招募中未知
Supportive management of IgA nephropathy: a prospective study
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- one
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Biopsy proven primary IgA nephropathy with proteinuria>=1g/day
排除标准
- •1.Lack of informed consent
- •2.eGFR <30ml/min/1.73m2
- •3.Presence of crescents on kidney biopsy
- •4.History of immunosuppressive therapy in last 6 months for more than 2 weeks
- •5. Past history of use of Angiotensin converting enzyme inhibitors(ACEi) or Angiotensin receptor blockers(ARBS) in the previous 6 months
- •5.Patients with a second coexisting disease on kidney biopsy like diabetic nephropathy
- •6.Secondary causes of IgA nephropathy like chronic liver disease, Henoch Schonlein Purpura
- •7.Patient who is pregnant or breast feeding at the time of recruitment
研究者
相似试验
招募中
4 期
Dapagliflozin treatment in IgA nephropathy patientsIgA nephropathyJPRN-jRCT1031220369Tomohito Gohda150
终止
4 期
Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive TreatmentIgANGlomerulonephritisNCT02523768Centre Hospitalier Universitaire de Saint Etienne117
招募中
不适用
Supplemental diagnostic methods of IgA nephropathy using morphological studies of urinary erythrocytes and tonsil biopsies in the patients with isolated hematuria.JPRN-UMIN000003844ational Defense Medical College30
招募中
不适用
Effect of Immunosuppression in IgA nephropathyKCT0003039Yonsei University Health System, Severance Hospital172
进行中（未招募）
1 期
Prevención en receptor con nefropatía por IgA (NIgA) de la Recurrencia completa trAs primer Trasplante renal: ATG-F versus Basiliximab como tratamientos inmunosupresores de inducción - PIRAT AvsBTrasplante renal de donante vivo o cadavéricoMedDRA version: 11Level: LLTClassification code 10023438Term: Trasplante de riñónMedDRA version: 11Level: HLTClassification code 10018365Term: Glomerulonefritis (incl síndrome nefrótico)MedDRA version: 11Level: LLTClassification code 10069341Term: Enfermedad de BergerEUCTR2009-018189-36-ESCHU de Saint-Étienne212